Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:263604.
doi: 10.1155/2014/263604. Epub 2014 Jun 3.

Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives

Affiliations
Review

Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives

Ranjan Ku Sahoo et al. Biomed Res Int. 2014.

Abstract

With the recent advancement in the field of ocular therapy, drug delivery approaches have been elevated to a new concept in terms of nonionic surfactant vesicles (NSVs), that is, the ability to deliver the therapeutic agent to a patient in a staggered profile. However the major drawbacks of the conventional drug delivery system like lacking of permeability through ocular barrier and poor bioavailability of water soluble drugs have been overcome by the emergence of NSVs. The drug loaded NSVs (DNSVs) can be fabricated by simple and cost-effective techniques with improved physical stability and enhance bioavailability without blurring the vision. The increasing research interest surrounding this delivery system has widened the areas of pharmaceutics in particular with many more subdisciplines expected to coexist in the near future. This review gives a comprehensive emphasis on NSVs considerations, formulation approaches, physicochemical properties, fabrication techniques, and therapeutic significances of NSVs in the field of ocular delivery and also addresses the future development of modified NSVs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of eye.
Figure 2
Figure 2
Structure of niosome.

Similar articles

Cited by

References

    1. Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems—recent advances. Progress in Retinal and Eye Research. 1998;17(1):33–58. - PubMed
    1. Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Investigative Ophthalmology and Visual Science. 2004;45(7):2342–2347. - PubMed
    1. Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. The AAPS journal. 2010;12(3):348–360. - PMC - PubMed
    1. Kaur IP, Kanwar M. Ocular preparations: the formulation approach. Drug Development and Industrial Pharmacy. 2002;28(5):473–493. - PubMed
    1. Gaudana R, Jwala J, Boddu SHS, Mitra AK. Recent perspectives in ocular drug delivery. Pharmaceutical Research. 2009;26(5):1197–1216. - PMC - PubMed

Publication types

MeSH terms